Acute and chronic viral hepatitis revisited.
暂无分享,去创建一个
[1] S. Sherlock,et al. Successful treatment of HBs and HBeAg positive chronic liver disease: prolonged inhibition of viral replication by highly soluble adenine arabinoside 5'-monophosphate (ARA-AMP). , 1982, Gut.
[2] S. Sherlock. Landmark perspective: Landmarks in viral hepatitis. , 1984, JAMA.
[3] Arie J. Zuckerman,et al. Developing synthetic vaccines , 1982, Nature.
[4] D. Shafritz,et al. Detection of Hepatitis B Virus DNA Directly in Human Serum by a Simplified Molecular Hybridization Test: Comparison to HBeAg/ Anti‐HBe Status in HBsAg Carriers , 2007, Hepatology.
[5] C. Burrell,et al. Hepatitis B reservoirs and attack rates in an Australian community: A basis for vaccination and crossinfection policies , 1983, The Medical journal of Australia.
[6] S. Sherlock,et al. Effects of prednisolone/azathioprine in chronic hepatitis B viral infection. , 1982, Gut.
[7] S. Sherlock,et al. The pathology of hepatitis A in man. , 2008, Liver.
[8] S. Sherlock,et al. Hepatitis B Virus Infection: The Impact of Molecular Biology , 2007, Hepatology.
[9] L. Overby,et al. Serodiagnosis of Recent Hepatitis B Infection by IgM Class Anti‐HBc , 2007, Hepatology.
[10] F. Tsuda,et al. Immunoglobulin M Antibody Against Hepatitis B Core Antigen for the Diagnosis of Fulminant Type B Hepatitis , 1983 .
[11] F. Deinhardt,et al. CLINICAL EVALUATION OF A RECOMBINANT HEPATITIS B VACCINE , 1984, The Lancet.
[12] J. Dienstag. Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features , 1983 .
[13] S. Sherlock,et al. Thrice weekly lymphoblastoid interferon is effective in inhibiting hepatitis B virus replication. , 2008, Liver.
[14] A. Lok,et al. Diminished responsiveness of homosexual men to antiviral therapy for HBsAg-positive chronic liver disease. , 1985, Journal of hepatology.
[15] H. Thomas,et al. An Analysis of the Composition of the Inflammatory Infiltrate in Autoimmune and Hepatitis B Virus‐Induced Chronic Liver Disease , 2007, Hepatology.
[16] S. Sherlock,et al. Significance of delta agent infection in chronic hepatitis B virus infection: a study in British carriers. , 1983, Gut.
[17] A. Beale. Vaccine development: Hybrid vaccinia virus for mass hepatitis immunization? , 1983, Nature.
[18] S. Sherlock. Different hepatitis B vaccines. , 1983, Scandinavian journal of infectious diseases. Supplementum.
[19] E. Sagnelli,et al. Effect of Immunosuppressive Therapy on HBsAg‐Positive Chronic Active Hepatitis in Relation to Presence or Absence of HBeAg and Anti‐HBe , 2007, Hepatology.
[20] N PRIMOST,et al. Agreed medical evidence. , 1962, Lancet.
[21] S. Sherlock. Landmarks in Viral Hepatitis , 1984 .
[22] J. Melnick,et al. Posttransfusion hepatitis type A. , 1983, JAMA.
[23] M. Rizzetto,et al. The Delta Agent , 2007, Hepatology.
[24] J. Hoofnagle,et al. Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis. , 1981, Annals of internal medicine.
[25] Gordon R. Dreesman,et al. Antibody to hepatitis B surface antigen after a single inoculation of uncoupled synthetic HBsAg peptides , 1982, Nature.
[26] C. Bréchot,et al. Detection of Hepatitis B Virus DNA in Serum by a Simple Spot Hybridization Technique: Comparison with Results for Other Viral Markers , 2007, Hepatology.